Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
- PMID: 33915353
- PMCID: PMC8054612
- DOI: 10.1016/j.thromres.2021.04.016
Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
Conflict of interest statement
None.
References
-
- Hogan M., Berger J.S. Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management. Vasc. Med. 2020;25(2):160–173. - PubMed
-
- Gruel Y., De Maistre E., Pouplard C., et al. Diagnosis and management of heparin-induced thrombocytopenia. Anaesth Crit Care Pain Med. 2020;39(2):291–310. - PubMed
-
- Selleng K., Warkentin T.E., Greinacher A. Heparin-induced thrombocytopenia in intensive care patients. Crit. Care Med. 2007;35(4):1165–1176. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources